Sanofi Appoints Belén Garijo to Steer Growth Amid Investor Concerns, Replacing Hudson

Araverus Team|Thursday, February 12, 2026 at 7:42 AM

Araverus Team

Feb 12, 2026 · 7:42 AM

BeléN Garijo · CEO Change · Pharmaceuticals · Sanofi

BeléN Garijo CEO Change Pharmaceuticals Sanofi

Sanofi has appointed Belén Garijo, the CEO of Merck KGaA, as its new chief executive following the decision not to renew Paul Hudson's mandate, amid investor concerns and declining vaccine demand.

Sanofi Appoints Belén Garijo to Steer Growth Amid Investor Concerns, Replacing Hudson

Read More On

Related Articles

Sanofi Shares Fall After CEO Change

Kroger Names Ex-Walmart Executive as Its Next CEO

Kroger Plans to Name an Ex-Walmart Executive as Its Next CEO

Toyota CEO to Step Down as Carmaker Navigates Trump Tariffs

Sanofi Appoints Belén Garijo to Steer Growth Amid Investor Concerns, Replacing Hudson

Read More On

Related Articles

Sanofi Shares Fall After CEO Change

Kroger Names Ex-Walmart Executive as Its Next CEO

Kroger Plans to Name an Ex-Walmart Executive as Its Next CEO

Toyota CEO to Step Down as Carmaker Navigates Trump Tariffs